Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 2
2008 3
2009 1
2010 4
2011 5
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Results by year
Filters applied: . Clear all
Page 1
MicroRNAs in malignant progression.
Ma L, Weinberg RA. Ma L, et al. Cell Cycle. 2008 Mar 1;7(5):570-2. doi: 10.4161/cc.7.5.5547. Epub 2007 Dec 31. Cell Cycle. 2008. PMID: 18256538 Review.
Characterization of the Melanoma miRNAome by Deep Sequencing.
Stark MS, Tyagi S, Nancarrow DJ, Boyle GM, Cook AL, Whiteman DC, Parsons PG, Schmidt C, Sturm RA, Hayward NK. Stark MS, et al. PLoS One. 2010 Mar 12;5(3):e9685. doi: 10.1371/journal.pone.0009685. PLoS One. 2010. PMID: 20300190 Free PMC article.
miRNA profiling along tumour progression in ovarian carcinoma.
Vaksman O, Stavnes HT, Kaern J, Trope CG, Davidson B, Reich R. Vaksman O, et al. J Cell Mol Med. 2011 Jul;15(7):1593-602. doi: 10.1111/j.1582-4934.2010.01148.x. J Cell Mol Med. 2011. PMID: 20716115 Free PMC article.
miRNAs can predict prostate cancer biochemical relapse and are involved in tumor progression.
Fendler A, Jung M, Stephan C, Honey RJ, Stewart RJ, Pace KT, Erbersdobler A, Samaan S, Jung K, Yousef GM. Fendler A, et al. Int J Oncol. 2011 Nov;39(5):1183-92. doi: 10.3892/ijo.2011.1128. Epub 2011 Jul 18. Int J Oncol. 2011. PMID: 21769427
MicroRNAs associated with metastatic prostate cancer.
Watahiki A, Wang Y, Morris J, Dennis K, O'Dwyer HM, Gleave M, Gout PW, Wang Y. Watahiki A, et al. PLoS One. 2011;6(9):e24950. doi: 10.1371/journal.pone.0024950. Epub 2011 Sep 30. PLoS One. 2011. PMID: 21980368 Free PMC article.
miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215.
White NM, Khella HW, Grigull J, Adzovic S, Youssef YM, Honey RJ, Stewart R, Pace KT, Bjarnason GA, Jewett MA, Evans AJ, Gabril M, Yousef GM. White NM, et al. Br J Cancer. 2011 Nov 22;105(11):1741-9. doi: 10.1038/bjc.2011.401. Epub 2011 Oct 27. Br J Cancer. 2011. PMID: 22033272 Free PMC article.
MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression.
Scapoli L, Palmieri A, Lo Muzio L, Pezzetti F, Rubini C, Girardi A, Farinella F, Mazzotta M, Carinci F. Scapoli L, et al. Int J Immunopathol Pharmacol. 2010 Oct-Dec;23(4):1229-34. doi: 10.1177/039463201002300427. Int J Immunopathol Pharmacol. 2010. PMID: 21244772 Free article.
miR-378(∗) mediates metabolic shift in breast cancer cells via the PGC-1β/ERRγ transcriptional pathway.
Eichner LJ, Perry MC, Dufour CR, Bertos N, Park M, St-Pierre J, Giguère V. Eichner LJ, et al. Cell Metab. 2010 Oct 6;12(4):352-361. doi: 10.1016/j.cmet.2010.09.002. Cell Metab. 2010. PMID: 20889127 Free article.
A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL.
Han BW, Feng DD, Li ZG, Luo XQ, Zhang H, Li XJ, Zhang XJ, Zheng LL, Zeng CW, Lin KY, Zhang P, Xu L, Chen YQ. Han BW, et al. Hum Mol Genet. 2011 Dec 15;20(24):4903-15. doi: 10.1093/hmg/ddr428. Epub 2011 Sep 17. Hum Mol Genet. 2011. PMID: 21926415 Free PMC article.
MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis.
Wu ZS, Wu Q, Wang CQ, Wang XN, Wang Y, Zhao JJ, Mao SS, Zhang GH, Zhang N, Xu XC. Wu ZS, et al. BMC Cancer. 2010 Oct 9;10:542. doi: 10.1186/1471-2407-10-542. BMC Cancer. 2010. PMID: 20932331 Free PMC article.
14 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page